Society for Immunotherapy of Cancer (SITC)

This #GivingTuesday, honor the memory of Dr. Jeffrey Weber, a pioneering force in immunotherapy research. Dr. Jeffrey Weber’s work in immunotherapy transformed the lives of countless patients and your contribution to SITC's memorial fund will help launch the careers of young cancer researchers shaping tomorrow’s immunotherapy breakthroughs. Learn more and donate: https://lnkd.in/dmrhh2jG

Implement spatial biology-based approaches, such as multiplex fluorescence to assess immuno-oncological markers and patient response. Join the #virtual Advances in Cancer Immunotherapy: A Focus on Pathology program Dec. 10.   Learn more: https://lnkd.in/g3nKd4pm PROGRAM HIGHLIGHTS  • Discuss predictive markers in clinical use with cancer immunotherapies and their relevance to cancer immunotherapy approaches. • Summarize recent updates in newly approved FDA immunotherapies and their impact on diagnostics. • Describe the importance of pathologic response evaluation and its correlation with outcomes, specifically in the neoadjuvant setting. • Implement spatial biology-based approaches, such as multiplex fluorescence to assess immuno-oncological markers and patient response. Thank you to all of our organizers and faculty members, Janis M. Taube, MD, MSc, The Johns Hopkins University School of Medicine, Julie Stein Deutsch, MD, The Johns Hopkins University School of Medicine, Tricia Cottrell, MD, PhD, Queen's University, Chen Hu, PhD, The Johns Hopkins University School of Medicine, Scott Rodig MD, PhD, Brigham and Women's Hospital and Dana-Farber Cancer Institute and poh sheng JOE YEONG, MBBS, PhD, FRCPath(UK), Singapore General Hospital.

Attention #SITC Members! Apply to our volunteer opportunities for the 2025-2026 term. Deadline to apply is Fri., Dec. 6. Join SITC’s volunteer pool and update your profile to get started. https://lnkd.in/ged7Scc4 #SITCquestfor100

Deal ends tomorrow! Make sure to take advantage of 30% off a single, 3- or 5- pack of job posts through the Career Connections Online Job Board. Use the discount code SITC2024 and learn more here: https://lnkd.in/ecKbCyu

Integrate immunotherapy into your clinical practice with a Certificate in #Cancer #Immunotherapy from @sitcancer. Explore eight expert-led modules, approved for CME, CNE, CPE & MOC credit. Register at https://lnkd.in/eeCFCV2m

Exciting Opportunity Alert! Looking to delve into the forefront of cancer immunotherapy and tumor immunology? Register now for the #SITC Winter School 2025! Expand your knowledge on the core principles of tumor immunology and cancer immunotherapy while exploring recent advancements in drug and biomarker technologies. Join us to discuss their clinical applications and unravel the mysteries of cancer treatment. Don't miss out on this invaluable opportunity to connect with leading experts and peers in the field. Visit https://lnkd.in/gcUHPdQk to learn more and secure your spot today! Early registration deadline is Jan. 6, 2025. Save $250 off the regular rates #Immunology #CancerResearch #Education #SITCWinterSchool2025 Program Organizers: Kristin Anderson from University of Virginia Chrystal Paulos from Winship Cancer Institute of Emory University Daniel Powell Jr., PhD from University of Pennsylvania. Program Advisor: Christian Capitini, MD from University of Wisconsin-Madison

The SITC Head and Neck Squamous Cell Carcinoma (HNSCC) clinical practice guideline (CPG) rapid update v1.1 includes new/revised clinical recommendations related to the use of ICI-based treatments for HNSCC, including: • Pembrolizumab for the treatment of R/M cutaneous squamous cell carcinoma • Toripalimab as monotherapy, or with cisplatin and gemcitabine for the treatment of metastatic or recurrent locally advanced nasopharyngeal carcinoma • Changes to the treatment landscape of R/M HNSCC, including new data on ICI monotherapies and ICI + chemotherapy combinations Visit the SITC HNSCC CPG as published in Journal for ImmunoTherapy of Cancer to view the current recommendations, including these rapid updates! https://lnkd.in/gGtibCsH Rapid updates are made possible through the SITC Living Guideline protocols. For more information on Living Guidelines, visit our website. https://lnkd.in/grZ7iFrh Thank you to the SITC HNSCC Expert Panel for their contributions, Barbara Burtness, MD, Yale Cancer Center, Robert Ferris, MD, PhD, UNC Lineberger Comprehensive Cancer Center, R. Bryan Bell, MD, DDS, FACS, Providence Cancer Institute, Carlo Bifulco, MD, Providence Genomics, Maura Gillison, MD, PhD, The University of Texas MD Anderson Cancer Center, Kevin Harrington, PhD, FRCP, FRCR, The Institute of Cancer Research, Quynh-Thu Lee, MD, FACR, FASTRO, Stanford University, Nancy Lee, MD, Memorial Sloan Kettering Cancer Center, Rom Leidner, MD, Providence Health & Services, Lisa Licitra, MD, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Hisham Mehanna, PhD, University of Birmingham, Loren K. Mell, MD, FASTRO, UC San Diego, Adam Raben, MD, ChristianaCare, Andrew Sikora, MD, PhD, The University of Texas MD Anderson Cancer Center, Ravindra Uppaluri, MD, PhD, Dana-Farber Cancer Institute and Brigham and Women's Hospital and Dan Zandberg, UPMC Hillman Cancer Center. #SITCGuidelines #HNSCC #cSCC #Immunotherapy

Access our free #CME education on non-small cell #lungcancer (#NSCLC) led by a panel of thoracic #oncologists! Uncover key updates for advanced or metastatic NSCLC & patient-centered treatment strategies for special populations. Watch now: https://bit.ly/3zQRezd Medlive - A PlatformQ Health Brand

Hi everyone, we're happy to announce that you can find us on Bluesky @sitcancer.bsky.social! See you there! (BTW - Save the date for next year's Annual Meeting!)

The Career Connections deal ends on Nov. 30! Act now using discount code SITC2024 to save 30% on a single, 3- or 5- pack of job posts through the Career Connections Online Job Board. Learn more here: https://lnkd.in/ecKbCyu